Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 16, Pages 4864
Publisher
Baishideng Publishing Group Inc.
Online
2015-04-25
DOI
10.3748/wjg.v21.i16.4864
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Silencing of Inhibitors of Apoptosis Proteins with siRNAs: A Potential Anti-cancer Strategy for Hepatocellular Carcinoma
- (2014) Gang Li et al. Asian Pacific Journal of Cancer Prevention
- Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
- (2013) Makito Miyake et al. BMC CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Vascular Endothelial Growth Factor Induces CXCL1 Chemokine Release via JNK and PI-3K-Dependent Pathways in Human Lung Carcinoma Epithelial Cells
- (2013) Huey-Ming Lo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways
- (2013) Makito Miyake et al. LABORATORY INVESTIGATION
- The emerging role of CXC chemokines and their receptors in cancer
- (2012) Victoria Vinader et al. Future Medicinal Chemistry
- Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells
- (2012) Leyla Kavandi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The anti-cancer and anti-inflammatory actions of 1,25(OH)2D3
- (2011) E. Vanoirbeek et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment
- (2011) Ning Li et al. CANCER CELL
- The expression and role of CXC chemokines in colorectal cancer
- (2011) Hannelien Verbeke et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma
- (2010) Bhawna Sharma et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival
- (2010) Dietrich Doll et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- The inflammatory microenvironment of HCC – The plot becomes complex
- (2010) Jörg Schrader et al. JOURNAL OF HEPATOLOGY
- Present and future possibilities for early diagnosis of hepatocellular carcinoma
- (2010) Piotr Stefaniuk WORLD JOURNAL OF GASTROENTEROLOGY
- Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
- (2009) Chiara Gabellini et al. EUROPEAN JOURNAL OF CANCER
- Cellular and molecular pathways linking inflammation and cancer
- (2009) Chiara Porta et al. IMMUNOBIOLOGY
- Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion
- (2009) Seema Singh et al. INTERNATIONAL JOURNAL OF CANCER
- TGF-β effects on airway smooth muscle cell proliferation, VEGF release and signal transduction pathways
- (2009) Joo Hwa SHIN et al. RESPIROLOGY
- Multi-faceted roles for CXC-chemokines in prostate cancer progression
- (2008) David et al. Frontiers in Bioscience-Landmark
- Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures
- (2008) Marie-Caroline Dieu-Nosjean et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now